XML 24 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Equity Compensation Plans
3 Months Ended
Aug. 31, 2021
Equity Compensation Plans
7. EQUITY COMPENSATION PLANS
Incentive and
non-qualified
options to purchase shares of common stock have been granted to directors, officers and employees of Neogen under the terms of the Company’s stock option plans. These options are granted at an exercise price of not less than the fair market value of the stock on the date of grant. Options vest ratably over three and five year periods and the contractual terms are generally five or ten years. A summary of stock option activity during the three months ended August 31, 2021 follows:
 
           
Weighted-
 
           
Average
 
(Options in thousands)
  
Options
    
Exercise
Price
 
Options outstanding June 1, 2021
     2,957      $  30.38  
Granted
     —          —    
Exercised
     (5      27.71  
Forfeited
     (11      30.79  
    
 
 
          
Options outstanding August 31, 2021
     2,941      $ 30.38  
During the three-month periods ended August 31, 2021 and 2020, the Company recorded $1,690,000 and $1,681,000, respectively, of compensation expense related to its share-based awards.
The weighted-average fair value per share of stock options granted during fiscal year 2021, estimated on the date of grant using the Black-Scholes option pricing model, was $7.71. The fair value of stock options granted was estimated using the following weighted-average assumptions. No options were granted in the first quarter of fiscal year 2022.
 
    
FY 2021
 
Risk-free interest rate
     0.2
Expected dividend yield
     0.0
Expected stock price volatility
     31.3
Expected option life
     3.25 years  
The Company granted 118,250 restricted stock units (RSUs) to directors, officers and employees under the terms of the 2018 Omnibus Incentive Plan in fiscal year 2021, which vest ratably over three and five year periods. No RSUs were gra
n
ted in the first quarter of fiscal year 2022. RSUs have a weighted average value of $34.21 per share and will be expensed
on a
straight-line
 basis
 
over the remaining weighted-average period of 4.0 years. On August 31, 2021 there was $2,908,000 in unamortized compensation cost related to
non-vested
RSUs.
The Company offers eligible employees the option to purchase common stock at a 5% discount to the lower of the market value of the stock at the beginning or end of each participation period under the terms of the 2011 Employee Stock Purchase Plan; the discount is recorded in general and administrative expense. Total individual purchases in any year are limited to 10% of compensation.